1. Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma
   Michele Barone et al, 2019, World Journal of Gastroenterology CrossRef
2. The role of vascular endothelial growth factor −634 G/C and its soluble receptor on chronic liver disease and hepatocellular carcinoma
   Neneng Ratnasari et al, 2016, Arab Journal of Gastroenterology CrossRef
3. Prognostic Factors for Overall Survival in Patients with HCV-Related HCC Undergoing Molecular Targeted Therapies: Beyond a Sustained Virological Response
   Yasunori Minami et al, 2022, Cancers CrossRef
4. Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular Carcinoma
   Kyoko Oura et al, 2022, Journal of Hepatocellular Carcinoma CrossRef
5. Impact of Cardiovascular Risk Factors and Pharmacologic Treatments on Carotid Intraplaque Neovascularization Detected by Contrast-Enhanced Ultrasound
   Marco Magnoni et al, 2019, Journal of the American Society of Echocardiography CrossRef
6. ACE inhibitors: The secret to prevent cirrhosis complications and HCC in NAFLD?
   Mazen Noureddin et al, 2022, Hepatology CrossRef